Director, Pricing & Economics at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Bachelor's Degree
  • Extensive pharmaceutical industry experience; at least 3 years in areas related to pricing and reimbursement in US and/or WW pricing
  • Knowledge of, and expertise with, key pricing and reimbursement systems worldwide
  • Knowledge of the US healthcare system and reimbursement environment, market access customers and channels
  • Experience in US pricing analytics
  • Strong knowledge of analytical and conceptual tools, and pricing market research techniques, that are relevant to pricing and contracting
  • Strong strategic thinking skills and ability to apply in a variety of complex business situations
  • Excellent communication skills with ability to flex communication style across a broad and diverse set of international markets
  • Proven ability to communicate complex pricing analyses in simple terms
  • Demonstrated ability to manage multiple priorities and timelines
  • Proven focus on integrity and credibility
  • Understanding of marketing mix and the role of pricing and access as part of the mix
  • Willingness to travel (US/overseas) for key meetings and a variety of face-to-face interactions with matrix partners

Responsibilities

  • Provide leadership and expertise to prepare for items needing US Pricing Committee approval
  • Consolidate Brand Budget and LTFP Gross and Net Price projections for senior pricing leadership
  • Provide strong guidance and support for the development and implementation of US and/or Global pricing strategies for key products in partnership with Global MAx teams inclusive of pricing strategy teams
  • Evolve pricing and economics for brands in response to new indications/clinical data, updated competitive environment, new product launches/dosing or any other developments that impact the brand’s pricing and reimbursement
  • Utilize sophisticated analytics and strong financial acumen to evaluate impact of pricing scenarios on volume/revenue
  • Drive the development and implementation of US and/or Global pricing strategies particularly for key products in partnership with Global MAx teams inclusive of pricing strategy teams
  • Anticipate and analyze significant changes in both external and internal market pricing dynamics that may influence their products
  • Support pricing evaluations for business development opportunities
  • Analyze innovative contractual solutions for respected brands
  • Ensure US and/or Global Pricing Strategies/GOAs for their in-line brands are kept up to date with prevailing market conditions and competitive landscape
  • Support the DEX pricing evaluations as necessary, ensuring the key pricing input and insights are incorporated in the clinical study design process for optimized access & pricing conditions at launch
  • Provide expertise as needed for key pricing & reimbursement negotiations across the globe
  • Select and oversee work of external pricing research vendors and technical experts in the areas of pharmaceutical pricing & payer negotiations

Skills

Pricing Analytics
Pricing Strategy
Financial Modeling
Budget Forecasting
Long-Term Financial Planning
Revenue Analysis
Reimbursement Strategy
Competitive Analysis
Scenario Analysis
Leadership

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI